Automation of metabolic stability studies in microsomes, cytosol and plasma using a 215 Gilson liquid handler

被引:24
作者
Linget, JM [1 ]
du Vignaud, P [1 ]
机构
[1] Glaxo Wellcome France, Lab Rech, F-91951 Les Ulis, France
关键词
automated incubations; metabolic screening; microsomes; cytosol; plasma; reversed phase liquid chromatography;
D O I
10.1016/S0731-7085(98)00238-6
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A 215 Gilson liquid handler was used to automate enzymatic incubations using microsomes, cytosol and plasma. The design of automated protocols are described. They were based on the use of 96 deep well plates and on HPLC-based methods for assaying the substrate. The assessment of those protocols was made with comparison between manual and automated incubations, reliability and reproducibility of automated incubations in microsomes and cytosol. Examples of the use of those programs in metabolic studies in drug research, i.e. metabolic screening in microsomes and plasma were shown. Even rapid processes (with disappearance half lives as low as 1 min) can be analysed. This work demonstrates how stability studies can be automated to save time, render experiments involving human biological media less hazardous and may be improve inter-laboratory reproducibility. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:893 / 901
页数:9
相关论文
共 25 条
  • [1] THE ESTERASES - PERSPECTIVES AND PROBLEMS
    ALDRIDGE, WN
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1993, 87 (1-3) : 5 - 13
  • [2] ASCOLONE V, 1994, J CHROMATOGR-BIOMED, V657, P133
  • [3] BERTRAND M, 1993, ISSX M 26 29 SEPT TO
  • [4] Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions
    Bertz, RJ
    Granneman, GR
    [J]. CLINICAL PHARMACOKINETICS, 1997, 32 (03) : 210 - 258
  • [5] EVALUATION OF THE RELATIVE EFFICACY OF VARIOUS TECHNIQUES FOR DEPROTEINIZING PLASMA SAMPLES PRIOR TO HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS
    BLANCHARD, J
    [J]. JOURNAL OF CHROMATOGRAPHY, 1981, 226 (02): : 455 - 460
  • [6] Code EL, 1997, DRUG METAB DISPOS, V25, P985
  • [7] PICORNAVIRUS INHIBITORS - TRIFLUOROMETHYL SUBSTITUTION PROVIDES A GLOBAL PROTECTIVE EFFECT AGAINST HEPATIC-METABOLISM
    DIANA, GD
    RUDEWICZ, P
    PEVEAR, DC
    NITZ, TJ
    ALDOUS, SC
    ALDOUS, DJ
    ROBINSON, DT
    DRAPER, T
    DUTKO, FJ
    ALDI, C
    GENDRON, G
    OGLESBY, RC
    VOLKOTS, DL
    REUMAN, M
    BAILEY, TR
    CZERNIAK, R
    BLOCK, T
    ROLAND, R
    OPPERMANN, J
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (08) : 1355 - 1371
  • [8] Synthesis and cyclic GMP phosphodiesterase inhibitory activity of a series of 6-phenylpyrazolo [3,4-d]pyrimidones
    Dumaitre, B
    Dodic, N
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (08) : 1635 - 1644
  • [9] ERIKSSON LC, 1989, HEPATIC CYTOCHROME P, P9
  • [10] Fauchere JL, 1997, ANALUSIS, V25, P97